• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SNAI 转录因子介导肺纤维化中的上皮-间充质转化。

SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis.

机构信息

Department of Medicine, University of Giessen Lung Center, University of Giessen, Giessen, Germany.

出版信息

Thorax. 2009 Dec;64(12):1053-61. doi: 10.1136/thx.2009.121798. Epub 2009 Oct 22.

DOI:10.1136/thx.2009.121798
PMID:19850962
Abstract

BACKGROUND

Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterised by accumulation of activated (myo)fibroblasts and excessive extracellular matrix deposition. The enhanced accumulation of (myo)fibroblasts may be attributed, in part, to the process of transforming growth factor beta1 (TGFbeta1)-induced epithelial-mesenchymal transition (EMT), the phenotypic switching of epithelial to fibroblast-like cells. Although alveolar epithelial type II (ATII) cells have been shown to undergo EMT, the precise mediators and mechanisms remain to be resolved. The objective of this study is to investigate the role of SNAI transcription factors in the process of EMT and in IPF.

METHODS

Using quantitative reverse transcription-PCR (RT-PCR), immunofluorescence, immunohistochemistry, western blotting, as well as gain- and loss-of-function studies and functional assays, the role of SNAI1 and SNAI2 in TGFbeta1-induced EMT in ATII cells in vitro was assessed; and the expression of SNAI transcription factors was analysed in experimental and human IPF in vivo.

RESULTS

TGFbeta1 treatment increased the expression and nuclear accumulation of SNAI1 and SNAI2, in concert with induction of EMT in ATII cells. SNAI overexpression was sufficient to induce EMT, and small interfering RNA (siRNA)-mediated SNAI depletion attenuated TGFbeta1-induced ATII cell migration and EMT. SNAI expression was elevated in experimental and human IPF and localised to hyperplastic ATII cells in vivo.

CONCLUSIONS

The results demonstrate that TGFbeta1-induced EMT in ATII cells is essentially controlled by the expression and nuclear translocation of SNAI transcription factors. Increased SNAI1 and SNAI2 expression in experimental and human IPF in vivo suggests that SNAI-mediated EMT may contribute to the fibroblast pool in idiopathic pulmonary fibrosis.

摘要

背景

特发性肺纤维化(IPF)是一种致命的间质性肺疾病,其特征是激活的(肌)成纤维细胞积累和细胞外基质过度沉积。(肌)成纤维细胞的积累增加可能部分归因于转化生长因子β1(TGFβ1)诱导的上皮-间充质转化(EMT)过程,即上皮细胞向成纤维细胞样细胞的表型转换。尽管已经表明肺泡上皮细胞 II 型(ATII)细胞经历 EMT,但确切的介质和机制仍有待解决。本研究旨在探讨 SNAI 转录因子在 EMT 过程和 IPF 中的作用。

方法

使用定量逆转录-PCR(RT-PCR)、免疫荧光、免疫组织化学、Western blot 以及功能获得和功能丧失研究和功能测定,评估 SNAI1 和 SNAI2 在体外 TGFβ1 诱导的 ATII 细胞 EMT 中的作用;并分析实验性和人类 IPF 中 SNAI 转录因子的表达。

结果

TGFβ1 处理增加了 SNAI1 和 SNAI2 的表达和核积累,与 ATII 细胞 EMT 的诱导一致。SNAI 过表达足以诱导 EMT,而小干扰 RNA(siRNA)介导的 SNAI 耗竭减弱了 TGFβ1 诱导的 ATII 细胞迁移和 EMT。SNAI 在实验性和人类 IPF 中表达上调,并在体内定位于增生的 ATII 细胞。

结论

结果表明,TGFβ1 诱导的 ATII 细胞 EMT 主要由 SNAI 转录因子的表达和核易位控制。体内实验性和人类 IPF 中 SNAI1 和 SNAI2 表达增加表明 SNAI 介导的 EMT 可能有助于特发性肺纤维化中的成纤维细胞池。

相似文献

1
SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis.SNAI 转录因子介导肺纤维化中的上皮-间充质转化。
Thorax. 2009 Dec;64(12):1053-61. doi: 10.1136/thx.2009.121798. Epub 2009 Oct 22.
2
Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.颗粒物与基质硬度对上皮-间质转化的协同作用。
Res Rep Health Eff Inst. 2014 Nov(182):3-41.
3
Transforming growth factor-beta1 represses E-cadherin production via slug expression in lens epithelial cells.转化生长因子-β1通过晶状体上皮细胞中的蛞蝓蛋白表达抑制E-钙黏蛋白的产生。
Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2708-18. doi: 10.1167/iovs.06-0639.
4
Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis.凝胶蛋白是肺纤维化中转化生长因子-β/ Smad3依赖性上皮细胞迁移的直接靶点。
FASEB J. 2008 Jun;22(6):1778-89. doi: 10.1096/fj.07-083857. Epub 2008 Feb 1.
5
Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis.蛋白酶激活受体(PAR)-1 和 -3 驱动肺泡上皮细胞的上皮-间充质转化 - 在肺纤维化中的潜在作用。
Thromb Haemost. 2013 Aug;110(2):295-307. doi: 10.1160/TH12-11-0854. Epub 2013 Jun 6.
6
TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).转化生长因子-β1诱导人肺泡上皮细胞向间充质细胞转化(EMT)。
Respir Res. 2005 Jun 9;6(1):56. doi: 10.1186/1465-9921-6-56.
7
Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.舒尼替尼,一种小分子激酶抑制剂,可减轻博来霉素诱导的小鼠肺纤维化。
Tohoku J Exp Med. 2016 Aug;239(4):251-61. doi: 10.1620/tjem.239.251.
8
Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.组蛋白去乙酰化酶抑制剂可恢复肺泡II型上皮细胞中表面活性蛋白C的表达,并在体内减轻博来霉素诱导的肺纤维化。
Exp Lung Res. 2015;41(8):422-34. doi: 10.3109/01902148.2015.1060275. Epub 2015 Jul 7.
9
TGF-β induces sustained upregulation of SNAI1 and SNAI2 through Smad and non-Smad pathways in a human corneal epithelial cell line.TGF-β 通过 Smad 和非 Smad 通路诱导人角膜上皮细胞系中 SNAI1 和 SNAI2 的持续上调。
Invest Ophthalmol Vis Sci. 2011 Apr 14;52(5):2437-43. doi: 10.1167/iovs.10-5635.
10
Disruption of β-catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair.β-连环蛋白/CBP信号通路的破坏会抑制人气道上皮-间质转化及修复。
Int J Biochem Cell Biol. 2015 Nov;68:59-69. doi: 10.1016/j.biocel.2015.08.014. Epub 2015 Aug 24.

引用本文的文献

1
Angiopoietin-like protein 2 mediates vasculopathy-driven fibrogenesis in a mouse model of systemic sclerosis.血管生成素样蛋白2在系统性硬化症小鼠模型中介导血管病变驱动的纤维化形成。
J Clin Invest. 2025 Jun 20;135(15). doi: 10.1172/JCI177123. eCollection 2025 Aug 1.
2
Integrated multiomic analysis identifies TRIP13 as a mediator of alveolar epithelial type II cell dysfunction in idiopathic pulmonary fibrosis.综合多组学分析确定TRIP13是特发性肺纤维化中II型肺泡上皮细胞功能障碍的介质。
Biochim Biophys Acta Mol Basis Dis. 2025 Mar;1871(3):167572. doi: 10.1016/j.bbadis.2024.167572. Epub 2024 Nov 13.
3
effect of 1-methyltryptophan isomers on epithelial-mesenchymal transition transcription factors in tubular epithelial cells after ischemia-reperfusion injury.
1-甲基色氨酸异构体对缺血再灌注损伤后肾小管上皮细胞上皮-间充质转化转录因子的影响。
Arch Razi Inst. 2024 Apr 30;79(2):307-314. doi: 10.32592/ARI.2024.79.2.307. eCollection 2024 Apr.
4
Understanding myofibroblast origin in the fibrotic lung.了解肺纤维化中肌成纤维细胞的起源。
Chin Med J Pulm Crit Care Med. 2024 Sep 17;2(3):142-150. doi: 10.1016/j.pccm.2024.08.003. eCollection 2024 Sep.
5
MiR-21-5p knockdown inhibits epithelial to mesenchymal transition in A549 lung adenocarcinoma cells by upregulating RhoB.miR-21-5p 敲低通过上调 RhoB 抑制 A549 肺腺癌细胞中的上皮间质转化。
Mol Biol Rep. 2024 Jul 23;51(1):837. doi: 10.1007/s11033-024-09794-x.
6
O-GlcNAcylation controls pro-fibrotic transcriptional regulatory signaling in myofibroblasts.O-GlcNAcylation 控制肌成纤维细胞中促纤维化转录调控信号。
Cell Death Dis. 2024 Jun 3;15(6):391. doi: 10.1038/s41419-024-06773-9.
7
Dysregulated bidirectional epithelial-mesenchymal crosstalk: a core determinant of lung fibrosis progression.上皮-间质双向串扰失调:肺纤维化进展的核心决定因素
Chin Med J Pulm Crit Care Med. 2024 Mar;2(1):27-33. doi: 10.1016/j.pccm.2024.02.001.
8
Linking NLRP3 inflammasome and pulmonary fibrosis: mechanistic insights and promising therapeutic avenues.连接 NLRP3 炎性体与肺纤维化:机制见解和有前途的治疗途径。
Inflammopharmacology. 2024 Feb;32(1):287-305. doi: 10.1007/s10787-023-01389-5. Epub 2023 Nov 22.
9
TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2.TRIB3通过与MDM2直接相互作用抑制SLUG降解,从而促进肺纤维化。
Acta Pharm Sin B. 2023 Apr;13(4):1631-1647. doi: 10.1016/j.apsb.2023.01.008. Epub 2023 Jan 11.
10
Analysis of the safety and efficacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary fibrosis.不同血浆浓度的吡非尼酮治疗特发性肺纤维化患者的安全性和有效性分析。
Front Pharmacol. 2022 Nov 29;13:1055702. doi: 10.3389/fphar.2022.1055702. eCollection 2022.